Surekha Yadav, MBBS Resident UCSF Profile Clinical Divisions Molecular Imaging & Therapeutics Publications 177Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer. Patterns of Progression After Peptide Receptor Radiopharmaceutical Therapy. Prostate-Specific Membrane Antigen Radioligand Therapy in Patients with Aggressive-Variant Prostate Cancer. PSMA PET/CT-Derived Indicators and Outcomes After [177Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access Program. Can 177Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data. Pre- or post-chemotherapy: effect on PSMA uptake. See All Publications
